UA91376C2 - Рецептура с контролируемым высвобождением - Google Patents

Рецептура с контролируемым высвобождением

Info

Publication number
UA91376C2
UA91376C2 UAA200803717A UAA200803717A UA91376C2 UA 91376 C2 UA91376 C2 UA 91376C2 UA A200803717 A UAA200803717 A UA A200803717A UA A200803717 A UAA200803717 A UA A200803717A UA 91376 C2 UA91376 C2 UA 91376C2
Authority
UA
Ukraine
Prior art keywords
controlled release
release
release formulation
provides
effective amount
Prior art date
Application number
UAA200803717A
Other languages
English (en)
Ukrainian (uk)
Inventor
Пратибха С. Пилгаонкар
Махарук Т. Рустомджи
Анилкумар С. Ганди
Атул Келкар
Прадня Багде
Original Assignee
Рубикон Рисеч Пвт Лтд.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Рубикон Рисеч Пвт Лтд. filed Critical Рубикон Рисеч Пвт Лтд.
Publication of UA91376C2 publication Critical patent/UA91376C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Abstract

Изобретение касается пероральной лекарственной формы с контролируемым высвобождением, которая включает гранулы, которые включают смесь терапевтически эффективного количества активного вещества, которое имеет высокую растворимость в воде, и по меньшей мере, один неполимерный ингибитор высвобождения, причем указанные гранулы объединены, по меньшей мере, с одним рН-независимым ингибитором высвобождения, который не набухает, и спрессованы, причем указанная лекарственная форма обеспечивает контролируемое высвобождение активнодействующего компонента с уменьшенным начальным "взрывным" высвобождением.
UAA200803717A 2005-08-24 2006-08-24 Рецептура с контролируемым высвобождением UA91376C2 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN1001MU2005 2005-08-24

Publications (1)

Publication Number Publication Date
UA91376C2 true UA91376C2 (ru) 2010-07-26

Family

ID=37963478

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200803717A UA91376C2 (ru) 2005-08-24 2006-08-24 Рецептура с контролируемым высвобождением

Country Status (6)

Country Link
US (1) US20080248107A1 (ru)
EP (1) EP1942875B1 (ru)
RU (1) RU2385712C2 (ru)
UA (1) UA91376C2 (ru)
WO (1) WO2007052299A2 (ru)
ZA (1) ZA200802602B (ru)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10026698A1 (de) 2000-05-30 2001-12-06 Basf Ag Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung
CA2359812C (en) 2000-11-20 2004-02-10 The Procter & Gamble Company Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures
CA2533150C (en) 2003-07-25 2013-03-12 Warner Chilcott Company, Inc. A doxycycline metal complex in a solid dosage form
US8377952B2 (en) 2003-08-28 2013-02-19 Abbott Laboratories Solid pharmaceutical dosage formulation
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
WO2006078925A2 (en) * 2005-01-21 2006-07-27 Warner Chilcott Company, Inc. A tetracycline metal complex in a solid dosage form
WO2007143158A2 (en) 2006-06-01 2007-12-13 Schering-Plough Healthcare Products, Inc. Sustained release pharmaceutical formulation comprising phenylephrine
EA015304B1 (ru) 2006-08-03 2011-06-30 Нитек Фарма Аг Лечение ревматоидного заболевания глюкокортикоидами с отсроченным высвобождением
KR101094231B1 (ko) * 2008-02-18 2011-12-14 하나제약 주식회사 서방성 고형 제제 및 그의 제조방법
EP2452677A1 (en) * 2008-09-29 2012-05-16 Wockhardt Limited Extended release dosage form of ropinirole
NZ582836A (en) * 2009-01-30 2011-06-30 Nitec Pharma Ag Delayed-release glucocorticoid treatment of rheumatoid arthritis by improving signs and symptoms, showing major or complete clinical response and by preventing from joint damage
WO2010135053A2 (en) * 2009-05-21 2010-11-25 Bionex Pharmaceuticals Llc Dual and single layer dosage forms
US8741343B2 (en) 2009-12-02 2014-06-03 Adamas Pharmaceuticals, Inc. Method of administering amantadine prior to a sleep period
IL210279A0 (en) 2009-12-25 2011-03-31 Dexcel Pharma Technologies Ltd Extended release compositions for high solubility, high permeability acdtive pharmaceutical ingredients
EP2366378A1 (en) 2010-03-01 2011-09-21 Dexcel Pharma Technologies Ltd. Sustained-release donepezil formulations
WO2011128914A2 (en) * 2010-04-15 2011-10-20 Cadila Healthcare Limited Extended release pharmaceutical compositions of pramipexole
AU2011256928A1 (en) 2010-05-24 2012-12-20 Lupin Limited Extended release formulation of pramipexole
US20130267560A1 (en) * 2010-10-22 2013-10-10 Cadila Healthcare Limited Sustained release pharmaceutical compositions of donepezil
KR20120122558A (ko) * 2011-04-29 2012-11-07 주식회사 바이오파마티스 도네페질 또는 이의 약학적으로 허용되는 염을 포함하는 용출 안정성이 개선된 서방형 약학 조성물 및 이의 제조방법
US9119793B1 (en) 2011-06-28 2015-09-01 Medicis Pharmaceutical Corporation Gastroretentive dosage forms for doxycycline
US10842802B2 (en) 2013-03-15 2020-11-24 Medicis Pharmaceutical Corporation Controlled release pharmaceutical dosage forms
US10154971B2 (en) 2013-06-17 2018-12-18 Adamas Pharma, Llc Methods of administering amantadine
GB201420311D0 (en) 2014-11-14 2014-12-31 Bio Images Drug Delivery Ltd Pharmaceutical processing
GB201420306D0 (en) 2014-11-14 2014-12-31 Bio Images Drug Delivery Ltd Compositions
GB201420300D0 (en) 2014-11-14 2014-12-31 Bio Images Drug Delivery Ltd Tablet
WO2016091805A2 (de) * 2014-12-08 2016-06-16 Develco Pharma Schweiz Ag Naloxon-monopräparat und mehrschichttablette
CN105496967B (zh) * 2015-12-22 2018-07-03 江苏苏南药业实业有限公司 盐酸雷尼替丁控释干混悬剂及其制备方法
US10342886B2 (en) 2016-01-26 2019-07-09 S.C. Johnson & Son, Inc. Extruded wax melt and method of producing same
US10010638B2 (en) 2016-06-14 2018-07-03 S. C. Johnson & Son, Inc. Wax melt with filler
CN106138004B (zh) * 2016-08-24 2019-03-15 石药集团欧意药业有限公司 一种己酮可可碱缓释片及其制备方法
CN107811985B (zh) * 2016-09-13 2021-05-28 四川科瑞德制药股份有限公司 一种抗癫痫缓释制剂及其制备方法与用途
WO2019040748A1 (en) 2017-08-24 2019-02-28 Adamas Pharma, Llc AMANTADINE COMPOSITIONS, THEIR PREPARATION, AND METHODS OF USE
CN110917144A (zh) * 2019-11-30 2020-03-27 江苏艾兰得营养品有限公司 一种骨架型维生素c缓释微丸及其制备方法
CN110917175A (zh) * 2019-12-05 2020-03-27 广东东阳光药业有限公司 一种美托洛尔缓释组合物及其制备方法
CN112516105A (zh) * 2020-12-10 2021-03-19 成都恒瑞制药有限公司 一种氯沙坦钾口服制剂及其制备方法
KR20230136513A (ko) * 2020-12-25 2023-09-26 인벤티아 헬스케어 리미티드 비타민 c의 안정한 서방성 제형 및 이의 제조 방법
CN115093425B (zh) * 2022-07-11 2024-02-02 河北奥星集团药业有限公司 盐酸纳洛酮的合成方法及在复方盐酸替利定缓释制剂中的应用
CN115252583B (zh) * 2022-07-11 2023-08-08 河北奥星集团药业有限公司 复方盐酸替利定缓释制剂及其制备方法
CN115120568B (zh) * 2022-07-11 2023-08-22 河北奥星集团药业有限公司 复方盐酸替利定缓释片及其制备方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8813064D0 (en) * 1988-06-02 1988-07-06 Euro Celtique Sa Controlled release dosage forms having defined water content
US5656296A (en) * 1992-04-29 1997-08-12 Warner-Lambert Company Dual control sustained release drug delivery systems and methods for preparing same
JP5170723B2 (ja) * 1997-01-10 2013-03-27 アボット・ラボラトリーズ 活性薬剤の制御放出用錠剤
WO1999001111A1 (en) * 1997-07-02 1999-01-14 Euro-Celtique, S.A. Stabilized sustained release tramadol formulations
US6491953B1 (en) * 2000-01-07 2002-12-10 Amcol International Corporation Controlled release compositions and method
DE10014588A1 (de) * 2000-03-27 2001-10-04 Basf Ag Wirkstoffhaltige Schwimmformen enthaltend Polyvinylacetat und Polyvinylpyrrolidon, deren Verwendung und Herstellung
DE10015479A1 (de) * 2000-03-29 2001-10-11 Basf Ag Feste orale Darreichungsformen mit retardierter Wirkstofffreisetzung und hoher mechanischer Stabilität
DE10029201A1 (de) * 2000-06-19 2001-12-20 Basf Ag Verfahren zur Herstellung fester oraler Darreichungsformen mit retardierender Wirkstoffreisetzung
WO2002067905A1 (en) * 2001-02-27 2002-09-06 Kos Pharmaceuticals, Inc. A sustained release pharmaceutical formulation
DE60206049T2 (de) * 2001-05-31 2006-06-14 Koninkl Philips Electronics Nv Frequenzregelkreis, taktwiederherstellungsschaltung und empfänger
WO2003004009A1 (en) * 2001-07-02 2003-01-16 Geneva Pharmaceuticals, Inc. Pharmaceutical composition
DK1448235T3 (da) * 2001-11-30 2007-07-02 Pfizer Prod Inc Orale, farmaceutiske sammensætninger af 5,8,14-triaza-tetracyclo[10.3.1.0(2,11).0(4.9)]-hexadeca-2(11),3,5,7,9-pentaen med kontrolleret frigivelse
IL149055A0 (en) * 2002-04-09 2002-11-10 Karma Pharm Ltd Extended release composition comprising as active compound venlafaxine hydrochloride
US7985422B2 (en) * 2002-08-05 2011-07-26 Torrent Pharmaceuticals Limited Dosage form
MXPA05011446A (es) * 2003-04-24 2006-05-31 Jagotec Ag Tableta con liberacion retardada con geometria de nucleo definida.
US7115283B2 (en) * 2003-05-06 2006-10-03 Access Business Group International Llc Preparations for sustained release of nutraceuticals and methods of controllably releasing nutraceuticals
IN2003MU00504A (ru) * 2003-06-05 2005-05-13 Alembic Ltd
US20050112198A1 (en) * 2003-10-27 2005-05-26 Challapalli Prasad V. Bupropion formulation for sustained delivery
EA011374B1 (ru) * 2004-01-06 2009-02-27 Панацея Биотек Лимитед Нераспадающаяся твёрдая композиция для перорального применения с высокой дозой растворимых в воде лекарственных средств

Also Published As

Publication number Publication date
WO2007052299A3 (en) 2008-03-13
US20080248107A1 (en) 2008-10-09
ZA200802602B (en) 2009-10-28
EP1942875B1 (en) 2015-08-12
WO2007052299A2 (en) 2007-05-10
WO2007052299B1 (en) 2008-04-24
RU2008110884A (ru) 2009-09-27
RU2385712C2 (ru) 2010-04-10
EP1942875A2 (en) 2008-07-16

Similar Documents

Publication Publication Date Title
UA91376C2 (ru) Рецептура с контролируемым высвобождением
HK1132175A1 (en) Combination of a cholinesterase inhibitor and a compound with 5-ht6 receptor affinity
WO2007036952A3 (en) Novel sustained release dosage form
MX2010005175A (es) Comprimido dispersable oral.
MX2009004858A (es) Forma de dosificacion de imatinib procesada en fusion.
PT2038290E (pt) Moduladores de receptor do tipo toll 7
EP2379060A4 (en) PHARMACEUTICAL FORMULATIONS WITH EXTENDED RELEASE
WO2012027065A3 (en) Combination therapy for treatment of disease
ZA200807767B (en) Nitrogenated heterocyclic derivative, and pharmaceutical agent comprising the derivative as active ingredient
WO2006084164A3 (en) Gastric retention and controlled release delivery system
TR201907874T4 (tr) Düşük sülfat fukanlar kullanarak fibröz yapışmaları ya da inflamatuar hastalıkları inhibe etmeye yönelik farmasötik kompozisyonlar ve yöntemler.
SI1906939T1 (sl) Uporaba delno nevtraliziranega anionskega kopolimera (met)akrilata kot oplaščenje za izdelavo zdravila, ki sprošča aktivno učinkovino pri znižanih vrednostih pH
TW200735899A (en) Pharmaceutical dosage forms having immediate release and/or controlled release properties
EP1898849A4 (en) NEW PROGRAMS FOR CONTRAZEPTIVE DEVICES WITH CONTROLLED DRUG DELIVERY
TW200718689A (en) 2-Amino-quinazolin-5-ones
WO2007054573A3 (en) Anti-proliferative combination therapy comprising a platinum-based chemotherapeutic agent and egfr inhibitors or pyrimidine analogues
MX2007002898A (es) Tableta con liberacion gastrointestinal controlada en sitio y tiempo del ingrediente activo.
WO2007121088A3 (en) Combinations of therapeutic agents for treating cancer
MX2010002735A (es) Envase de titulacion para neramexano y su uso en el tratamiento de un trastorno del oido interno.
MX2009010167A (es) Composicion farmaceutica solida que comprende un derivado de bencimidazol-7-carboxilato y un agente para el control del ph.
NZ597648A (en) Angiotensin II receptor antagonist for the prevention or treatment of systemic diseases in cats
SG138567A1 (en) Punctal plugs for the delivery of active agents
SG138565A1 (en) Punctal plugs for the delivery of active agents
AR079049A1 (es) Combinacion terapeutica que comprende un inhibidor de cdc7 y un agente antineoplasico
MX2007010886A (es) Metodos y formulaciones de acarbosa para tratar constipacion cronica.